Last edition
News about "Morepen Laboratories"
Morepen Laboratories Completes First Phase of API and CDMO Capacity Expansion Ahead of Schedule
Morepen Laboratories has increased its installed reactor capacity from 535 KL to 614 KL, strengthening manufacturing readiness for commercial CDMO scale-up and supporting its API business and future customer programs.<br />
Morepen Laboratories | 07/09/2026 | By News Bureau | 394
Morepen Begins Commercial Supplies under INR 825 Crore CDMO Contract
Morepen has started commercial supplies under its INR 825 crore CDMO mandate, completing the first INR 50 crore dispatch in Q1 FY2026-27 and strengthening its contract manufacturing business.
Morepen Laboratories | 01/07/2026 | By News Bureau | 101
Morepen Laboratories Bags Zero-Observation USFDA Inspection for Fourth Time
Morepen Laboratories clears its fourth consecutive USFDA inspection at the Masulkhana facility with zero observations (NIL 483), reinforcing its CDMO strength following a INR 825 crore global manufacturing mandate.
Morepen Laboratories | 21/04/2026 | By News Bureau | 365
Morepen Bags INR 825 Crore Global Deal
Morepen has secured a ?825 crore global deal, marking its expansion into the high-growth Contract Development and Manufacturing Organisation (CDMO) segment.
Morepen Laboratories | 24/02/2026 | By News Bureau | 168
Morepen Medipath, Bimedical FZE Form Joint Venture to Foray into Medical Devices
Morepen Medipath (MML), a subsidiary of Morepen Laboratories, has signed a joint venture agreement with UAE-based Bimedical FZE to establish a new company in India focused on the medical devices sector.
Morepen Laboratories | 09/09/2025 | By Dineshwori | 453
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy